PC 40260018 - Acquisition of Aripiprazole 400MG
About This Opportunity
TranslatedThe tender PC 40260018 pertains to the acquisition of Aripiprazole 400MG, a medication used primarily in the treatment of various mental health conditions, including schizophrenia and bipolar disorder. This procurement is essential for ensuring the availability of this critical pharmaceutical product within the healthcare system. The tender outlines the need for suppliers to provide Aripiprazole in the specified dosage of 400MG, adhering to all relevant quality and safety standards. Interested bidders must demonstrate their capability to deliver the product in compliance with regulatory requirements and within the stipulated timeframes. Additionally, the tender may include specific packaging, labeling, and storage conditions that must be met to ensure the integrity and efficacy of the medication. The procurement is likely to take place within the public health sector, emphasizing the importance of timely and reliable access to essential medications for patient care. Suppliers are encouraged to submit their proposals, highlighting their experience in pharmaceutical distribution and their ability to meet the outlined specifications. This tender represents a significant opportunity for qualified vendors to contribute to the healthcare system by providing a vital medication that supports mental health treatment.
This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals and Mental Health. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 20,551.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender PC 40260018 seeks proposals for the procurement of Aripiprazole 400MG, a medication commonly used in the treatment of various psychiatric disorders, including schizophrenia and bipolar disorder.
This procurement is part of a broader initiative to enhance mental health services within Portugal, reflecting the country’s commitment to improving healthcare delivery and patient outcomes.
Bidders are invited to submit their offers for the supply of Aripiprazole in the specified dosage form. This tender is issued under the auspices of a relevant contracting authority in Portugal, which is responsible for managing public health procurement to ensure that high-quality medications are accessible to healthcare providers and patients.
Typical requirements for this type of tender may include compliance with regulatory standards for pharmaceuticals, evidence of appropriate quality control measures, and the ability to provide timely delivery of the product. Additionally, bidders might be expected to demonstrate experience in supplying similar medications to healthcare institutions, as well as compliance with any relevant environmental and safety regulations.
The procurement process will be conducted in accordance with Portuguese public procurement regulations, focusing on transparency and fairness.
Interested suppliers should prepare their submissions carefully, ensuring that all documentation is complete and aligns with the specified needs of the contracting authority. This tender represents an important opportunity for pharmaceutical suppliers to contribute to the enhancement of mental health care in Portugal.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 12, 2026. Last refreshed 1 day ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde do Nordeste, EPE
Unidade Local de Saúde do Nordeste, EPE has issued 305 procurement notices on BidsFactory, including 2 currently open and 285 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: May 21, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to LUNDBECK PORTUGAL - PRODUTOS FARMACÊUTICOS, LDA.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde do Nordeste, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €20,551. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.